Quick Search

PHDS HEALTHCARE RESEARCH Co., Ltd. (CRO) is a CRO company serving the world, a national high-tech enterprise, and one of the leading contract research institutions (Contract Research Organization) in the industry.

搜索历史清除全部记录
最多显示8条历史搜索记录噢~
All
  • All
  • Product Management
  • News

The CEO of Bozhi Star was invited to attend the Second Biopharmaceutical High-tech Trade Fair in Benxi, Liaoning.


Release time:

2009-08-01

From August 5 to 8, 2009, the CEO of Boshi Zhixing was invited to attend the "Liaoning (Benxi) Second Biopharmaceutical High-tech Trade Fair."

The CEO of Bozhi Star was invited to attend the Second Biopharmaceutical High-tech Trade Fair in Benxi, Liaoning.

From August 5 to 8, 2009, the CEO of BoShiZhiXing was invited to attend the "Liaoning (Benxi) Second Biopharmaceutical High-tech Trade Fair." This conference was hosted by the Ministry of Science and Technology and the People's Government of Liaoning Province, organized by the Liaoning Provincial Department of Science and Technology and the Benxi Municipal People's Government, with the support of the Chinese Pharmaceutical Association, the China Biotechnology Development Center, and Shenyang Pharmaceutical University.

Representatives from the pharmaceutical field, including those from the United States, Canada, the United Kingdom, and other countries and regions, as well as overseas Chinese representatives, attended this trade fair, with over 1,000 representatives from well-known domestic enterprises, higher education institutions, research institutes, and medical institutions. The conference focused on the theme of "Innovation, Investment, Cooperation, and Win-win," highlighting the characteristics of the biopharmaceutical and life health industries, with the main content centered on new product transactions, international scientific and technological exchanges and cooperation, project docking, and investment negotiations, aiming to attract domestic and foreign technological achievements and capital to participate in the development and construction of the Benxi Ecological New City, and striving to build a long-term cooperation platform for mutual benefit and win-win between biopharmaceutical enterprises and domestic and foreign research institutions.

It is understood that the trade fair attracted a total of 295 domestic and foreign enterprises to participate in exhibitions and negotiations. This includes over 40 well-known domestic and foreign enterprises such as the U.S. Alixis Company, the U.S. Kytos International Group, Tianjin Tasly Group, Northeast Pharmaceutical Group, Jilin Xiu Zheng Pharmaceutical Group, and Shijiazhuang Pharmaceutical Group, with 124 enterprises engaged in cooperation negotiations and 171 exhibiting enterprises.

Keyword:

Relevant regulations and policies


Key points and judgment principles for the quality management of non-clinical research of drugs

In order to standardize the on-site inspection work of Good Laboratory Practice (GLP) for non-clinical drug research and improve inspection quality, the "Key Points and Determination Principles for the Inspection of Good Laboratory Practice in Non-Clinical Drug Research" has been formulated in accordance with relevant requirements such as the "Drug Administration Law of the People's Republic of China," "Good Laboratory Practice for Non-Clinical Drug Research," and "Management Measures for the Certification of Good Laboratory Practice for Non-Clinical Drug Research."

2024-11-22

Technical requirements for the latest declaration data electronic disc

In order to further improve the quality and efficiency of the preparation of electronic application materials for drug registration, and to standardize the management of electronic application materials, our center has updated the "Technical Requirements for Electronic Discs of Application Materials" and "Structure of Electronic Documents for Drug Registration Applications" published on December 2, 2022, based on feedback.

2024-11-22

PHDS was elected as: Vice President unit of the China Food and Drug Enterprise Quality Safety Promotion Association

In December 2023, PHDS HEALTHCARE RESEARCH Co., Ltd. was elected as the vice president unit of the China Food and Drug Enterprise Quality Safety Promotion Association, as well as the vice chairman of its subordinate digital professional committee (Certificate No.: Zhong Shi Yao An Cu Hui Zheng Zi 798). The election and award ceremony took place at the Three Gorges Hospital of Chongqing Medical University.

2024-11-22

The Wuxi Global Oral Forum and the High-Quality Development Conference of the China Food and Drug Promotion Association -- Bo Shi Zhi Xing was elected as an executive council unit and an excellent member unit.

On March 26-27, 2024, the China Wuxi Global Oral Forum and the China Food and Drug Promotion Association High-Quality Development Conference, guided by the Wuxi Municipal People's Government and the Wuxi Council for the Promotion of International Trade, and organized by the China Food and Drug Promotion Association and the Oral Health Committee of the China Food and Drug Promotion Association, will be grandly held at the Wuxi International Conference Center.

2024-11-22